Colonic mucosal interleukin-6 in inflammatory bowel disease

Digestion

Volumn 50, Issue 2, 1991, Pages 104-111

  Mitsuyama, Keiichi ^a   Sasaki, Ei ^a   Toyonaga, Atsushi ^a   Ikeda, Hideo ^a   Tsuruta, Osamu ^a   Irie, Akira ^a   Arima, Nobuyuki ^a   Oriishi, Tetsuharu ^a   Harada, Kazunori ^a   Fujisaki, Kazuhiro ^a   Sata, Michio ^a   Tanikawa, Kyuichi ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Crohn s disease; Interleukin 6; Ulcerative colitis

Indexed keywords

CORTICOSTEROID; INTERLEUKIN 6; SALAZOSULFAPYRIDINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COLON MUCOSA; CONTROLLED STUDY; CROHN DISEASE; DRUG ACTIVITY; ENDOSCOPIC BIOPSY; ENTERITIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNITY; INFLAMMATION; MALE; PRIORITY JOURNAL; TISSUE LEVEL; ULCERATIVE COLITIS;

ADULT; BIOPSY; COLITIS, ULCERATIVE; COLON; CROHN DISEASE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INTERLEUKIN-6; INTESTINAL MUCOSA; MALE;

EID: 0026336617     PISSN: 00122823     EISSN: 14219867     Source Type: Journal    
DOI: 10.1159/000200747     Document Type: Article

References (36)

1. Horii Y, Muraguchi A, Suematsu S. Matsuda T. Yoshizaki K, Hirano T, Kishimoto T: Regulation of BSF-2/IL-6 production by human mononuclear cells. Macrophage-dependent synthesis of BSF-2/ IL-6 by T cells. J Immunol 1988; 141:1529-1535
2. Lotz M, Jirik F, Kabouridis R, Tsoukas C, Hirano T, Kishimoto T, Carson DA: BSF-2/IL-6 is costi-mulant for human thymocytes and T lymphocytes. J Exp Med 1988;167:1253-1258
3. Helle M, Brakenhoff JPJ, De Groot ER. Aarden LA: Interleukin 6 is involved in interleukin 1-induced activities. Eur J Immunol 1988; 18:957-959
4. Uyttenhove C, Coulie PG, Van Snick J: T cell growth and differentiation induced by interleu-kin-HPl/IL-6, the murine hybridoma/plasmacy-toma growth factor. J Exp Med 1988; 167:417-427
5. Le J, Fredrickson G, Reis LFL, Diamantstein T, Hirano T, Kishimoto T, Vilcek J: Interleukin 2-dependent and interleukin 2-independent pathways of regulation of thymocyte function by interleukin 6. Proc Natl Acad Sci USA 1988;85:8643-8647
6. Ceuppens JL, Baroja ML, Lorre K, Van Damme J, Billiau A: Human T cell activation with phytohe-magglutinin. The function of IL-6 as an accessory signal. J Immunol 1988;141:3868-3874
7. Muraguchi A, Hirano T, Tang B, Matsuda T, Horii Y, Nakajina K, Kishimoto T: The essential role of B-cell stimulatory factor 2 (BSF-2/IL-6) for the terminal differentiation of B cells. J Exp Med 1988;167:332-344
8. Takatsuki F, Okano A. Suzuki C, Chieda R. Taka-hara Y, Hirano T, Kishimoto T, Hamuro J, Akiyama Y: Human recombinant interleukin 6/B cell stimulatory factor 2 (IL-6/BSF-2) augments murine antigen-specific antibody responses in vitro and in vivo. J Immunol 1988; 141:3072-3077
9. Andus T, Geiger T. Hirano T, Northoff H, Ganter U, Bauer J, Kishimoto T, Heinrich PC: Recombinant human B cell stimulatory factor 2 (BSF-2/ IFN-β2) regulates p-fibrinogen and albumin mRNA levels in Fao-9 cells. FEBS Lett 1987;22I: 18-22
10. Castell JV, Gomez-Lechon MJ. David M, Hirano T, Kishimoto T, Heinrich PC: Recombinant human interleukin-6 (IL-6/BSF-2/HSF) regulated the synthesis of acute phase proteins in human hepatocytes. FEBS Lett 1988;232:347-350
11. Geiger T, Andus T, Klapproth J. Hirano T, Kishimoto T, Heinrich PC: Induction of rat acute-phase proteins by interleukin 6 in vivo. Eur J Immunol 1988;18:717-721
12. Kishimoto T, Hirano T: Molecular regulation of B lymphocyte response. Ann Rev Immunol I988;6: 485-512
13. Nijisten MWN, De Groot ER, Ten Duis HJ, Klasen J. Hack CE, Aarden LA: Serum levels of interleukin-6 and acute phase responses. Lancet 1987;2:921
14. Nishimoto N, Yoshizaki K, Tagoh H, Monden M, Kishimoto S, Hirano T, Kishimoto T: Elevation of serum interleukin 6 prior to acute phase proteins on the inflammation by surgical operation. Clin Immunol Immunopathol 1989;50:399-401
15. Brandtzaeg P, Halstensen TS, Kett K. Krajci P, Kvale D, Rognum TO, Scott H, Sollid LM: Immu-nobiology and immunopathology of human gut mucosa. Humoral immunity and intraepithelial lymphocytes. Gastroenterology 1989:97:1562-1584
16. MacDermott RP, Stenson WF: Inflammatory bowel disease; in Targan SR, Shanahan F (eds): Immunology and Immunopathology of the Liver and Gastrointestinal Tract, ed 1. New York/Tokyo, Igaku-Shoin, 1990, pp 459-486
17. Jewell DP, Snook JA: Immunology of ulcerative colitis and Crohn’s disease; in Allan RN, Keighley MRB, Alexander-Williams J, Hawkins CF (eds): Inflammatory Bowel Diseases, ed 2. Edinburgh. Churchill Livingstone. 1990, pp 127-146
18. Nixon JB, Riddell RH: Histopathology of ulcerative colitis; in Allan RN, Keighley MRB, Alexander-Williams J, Hawkins CF (eds): Inflammatory Bowel Disease, ed 2. Edinburgh, Churchill Livingstone, 1990, pp 247-262
19. Thompson H: Histopathology of Crohn’s disease; in Allan RN, Keighley MRB, Alexander-Williams J, Hawkins CF (eds): Inflammatory Bowel Diseases, ed 2. Edinburgh, Churchill Livingstone. 1990, pp 263-285
20. Matsuda T, Hirano T, Kishimoto T: Established of an interleukin 6 (IL 6)/B cell stimulatory factor 2-dependent cell line and preparation of anti-IL 6 monoclonal antibodies. Eur J Immunol 1988:18: 951-956
21. Mitsuyama K, Sata M, Tanikawa K: Significance of interleukin-6 in patients with inflammatory bowel disease. Gastroenterol Jpn 1991;26:20-28
22. Matts SGF: The value of rectal biopsy in the diagnosis of ulcerative colitis. Q J Med 1961; 120:393-407
23. Miki S, Iwano M, Miki Y, Yamamoto M, Tang B, Yokokawa K, Sonoda T, Hirano T, Kishimoto T: Interleukin-6 (IL-6) functions as an in vitro autocrine growth factor in renal cell carcinomas. FEBS Lett 1989;250:607-610
24. Ferguson A: Why study T cell subsets in Crohn’s disease? Gut 1983;24:687-691
25. Elson CO, Graeff AS, James SP, Strober W: Covert suppressor or T cells in Crohn’s disease. Gastroenterology 1981;80:1513-1521
26. James SP, Neckcrs LN, Graeff AS, Cossman J. Balch CM, Strober W: Suppression of immunoglobulin synthesis by lymphocyte subpopulations in patients with Crohn’s disease. Gastroenterology 1984;86:1510-1518
27. Pallone F, Fais S, Squarcia O, Biancone L, Pozzilli P, Biorivant M: Activation of peripheral blood and intestinal lamina propria lymphocytes in Crohn’s disease. In vivo state of activation and in vitro response to stimulation as defined by the expression of early activation antigens. Gut 1987; 28:745-753
28. Raedler A, Fraenkel S, Klose G, Seyfarth K, Thiele HG: Involvement of the immune system in the pathogenesis of Crohn’s disease. Gastroenterology 1985;88:978-983
29. Fagan EA, Dyck RF, Maton PN, Hodgson HJF. Chadwick VS. Petrie A, Pepys MB: Serum levels of C-reactive protein in Crohn’s disease and ulcerative colitis. Eur J Clin Invest 1982;12:351-360
30. Andre C, Descos L, Landais P, Fermanian J: Assessment of appropriate laboratory measurements to supplement the Crohn’s disease activity index. Gut 1981;22:571-574
31. Mahida YR, Wu K, Jewell DP: Enhanced production of interleukin 1 by mononuclear cells isolated from mucosa with active ulcerative colitis and Crohn’s disease. Gut 1989;30:835-838
32. Ligumsky M, Simon PL, Karmeli F, Rachmile-witz D: Role of interleukin 1 in inflammatory bowel disease. Enhanced production during active disease. Gut 1990:31:686-689
33. Fiocchi C, Hilfiker ML, Youngman KR. Doerder NC, Finke JH: Interleukin 2 activity of human intestinal mucosa mononuclear cells. Decreased levels in inflammatory bowel disease. Gastroenterology 1984;86:734-742
34. Fiocchi C, Youngman KR, Yen-Liebcrman B, Tubbs RR: Modulation of intestinal immune reactivity by interleukin 2. Phenotypic and functional analysis of lymphokine-activated killer cells from human intestinal mucosa. Dig Dis Sci 1988: 33:1305-1315
35. Akira S, Hirano T, Taga T, Kishimoto T: Biology of multifunctional cytokines. IL 6 and related molecules (IL I and TNF). FASEB J 1990;4: 2860-2867
36. Wong GG, Clark SC: Multiple actions of interleukin 6 within a cytokine network. Immunol Today 1988;9:137-139